Novo Nordisk
NVO
#28
Rank
โ‚น28.075 T
Marketcap
โ‚น6,288
Share price
-2.44%
Change (1 day)
-41.71%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2024 (TTM): โ‚น1.592 Trillion

According to Novo Nordisk's latest financial reports the company's current earnings are โ‚น41.89 Billion. , an increase over its 2023 earnings that were of โ‚น1.320 Trillion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2024

Annual earnings

Year Earnings Change
2024 โ‚น1.620 T22.75%
2023 โ‚น1.320 T57.64%
2022 โ‚น837.49 B5.35%
2021 โ‚น794.96 B12.47%
2020 โ‚น706.81 B13.07%
2019 โ‚น625.11 B-3.35%
2018 โ‚น646.78 B1.79%
2017 โ‚น635.38 B4.52%
2016 โ‚น607.90 B9.42%
2015 โ‚น555.58 B8.24%
2014 โ‚น513.29 B3.45%
2013 โ‚น496.18 B19.02%
2012 โ‚น416.90 B15.21%
2011 โ‚น361.88 B17.71%
2010 โ‚น307.42 B24.78%
2009 โ‚น246.36 B10.62%
2008 โ‚น222.70 B55.97%
2007 โ‚น142.78 B7.07%
2006 โ‚น133.36 B18.18%
2005 โ‚น112.84 B11.33%
2004 โ‚น101.36 B
2002 โ‚น65.11 B-14.39%
2001 โ‚น76.05 B-52.82%
2000 โ‚น161.18 B250%
1999 โ‚น46.05 B31.21%
1998 โ‚น35.09 B34.31%
1997 โ‚น26.13 B11.46%
1996 โ‚น23.44 B9.03%
1995 โ‚น21.50 B-3.15%
1994 โ‚น22.20 B-0.67%
1993 โ‚น22.34 B45.38%
1992 โ‚น15.37 B-13.81%
1991 โ‚น17.83 B37.12%
1990 โ‚น13.00 B-0.79%
1989 โ‚น13.11 B26.2%
1988 โ‚น10.38 B24.97%
1987 โ‚น8.31 B-0.9%
1986 โ‚น8.38 B-7.78%
1985 โ‚น9.09 B24.87%
1984 โ‚น7.28 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚น950.86 B-41.33%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.084 T-33.05%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น716.94 Billion-144.24%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น679.54 B-58.07%๐Ÿ‡ซ๐Ÿ‡ท France